Technology

Home>Technology
Aug 27 2020

Halberd Corporation Selects University Research Partner

By |2020-08-27T08:00:21-04:00August 27th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, August 27, 2020 – Halberd Corp. (OTC PINK: "HALB") is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd’s patented extracorporeal treatment of Covid-19.  Terms of the agreement have been finalized and ...

Aug 18 2020

Halberd Corporation CEO Answers Shareholders’ Questions Regarding Covid-19 Treatment

By |2020-08-18T08:00:11-04:00August 18th, 2020|Featured, Investor News, News, Technology|0 Comments

Jackson Center, PA, August 18, 2020 – Halberd Corp. (OTC PINK: "HALB") Chairman, President & CEO of Halberd Corporation, William A. Hartman, has received a number of questions from shareholders regarding the extracorporeal process for treatment of Covid-19. Below, Mr. Hartman responds to those questions. Q:  There are various extracorporeal medical procedures being researched or ...

Jul 7 2020

COVID-19 Cytokine Storm, Coronavirus’ Deadliest Stage – Halberd’s US Patent Pending Treatment Now Explained!

By |2020-07-06T19:47:51-04:00July 7th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, July 7, 2020 – Halberd Corp. (OTC PINK: "HALB") today explains the second of three (3) COVID -19 (Coronavirus) patent pending treatments - “Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patients” - which was filed with the U.S. Patent and Trademark Office on ...

Jun 29 2020

Halberd Method for Treating and Curing the COVID-19 Infection Explained

By |2020-06-28T19:55:51-04:00June 29th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 29, 2020 – Halberd Corporation (OTC-PINK: "HALB") today unveils the first of three (3) COVID -19 (Coronavirus) patent pending treatment methods -- the first titled, “Method for Treating and Curing Covid-19 Infection” -- filed with the U.S. Patent and Trademark Office on March 16, 2020.  Halberd holds exclusive worldwide license to ...

Jun 22 2020

NFL Retired Players Association’s Chief Medical Officer Joins Halberd Corporation to Lead COVID-19 Efforts

By |2020-06-21T20:27:29-04:00June 22nd, 2020|Featured, News, Technology|0 Comments

Effective Immediately! Jackson Center, PA, June 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to the position of Chief Technical Officer effective immediately.  He will report to Halberd’s new Chairman, President and CEO, William A. Hartman and is currently the Chief Medical Officer of the NFL’s Retired ...

Jun 15 2020

Halberd Designated “Pink Current Information” by OTC and Continues Technology Progress

By |2020-06-21T04:55:39-04:00June 15th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 15, 2020 –Halberd Corporation (OTC Pink: HALB) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Corporation and now designates Halberd Corporation as "Pink Current Information". William A. Hartman, newly appointed Chairman, President and CEO explains, “Now that Halberd has been designated by OTC ...

Jun 9 2020

Halberd Corporation Appoints Dr. Patricio Reyes to Scientific Advisory Board

By |2020-06-21T23:04:50-04:00June 9th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 9, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately  He will report to Halberd’s Chairman, President and CEO, William A. Hartman. Dr. Reyes, MD, FAAN, a board certified neurologist and neuropathologist, is a Board Member of the ...

Go to Top